India's SRI launches $100m US-India VC fund
SRI Capital has launched its debut fund, targeting innovative technology start-ups in the US and India, with a target of $100 million.
The fund is anchored by a $20 million commitment from the family office of founder and managing partner Sashi Reddi, who told VC Circle that the firm has already reached a first close of $40 million. Capital...
More on South Asia
Latest News
China's drug developer Sumgen raises $32m
Hangzhou-based drug developer Sumgen Biotech has raised RMB220 million ($32 million) in a Series B funding led by Addor Capital.
Corporate VCs & climate change: Good citizens
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Panacea leads $40m Series C for China's XWPharma
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Tencent backs Chinese healthcare cloud services platform
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.